Grantopen🌐 United StatesPAR-25-447

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Sep 22, 2025
Response deadline: May 8, 2028, 12:00 AM UTC (666d)
Type: Grant
Category: 93.837, 93.838, 93.839, 93.840, 93.233
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-447

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
United States · Dec 5, 2024
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
United States · Dec 18, 2024
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
United States · Nov 6, 2024
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
United States · Dec 5, 2024
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
United States · Oct 28, 2024
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
United States · Oct 30, 2024

Similar past solicitations

Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)
United States · Dec 30, 2024
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
United States · Nov 18, 2024
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
United States · Nov 18, 2024
Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
United States · Dec 5, 2023
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.